European Patent Office

T 1036/11 (Neurotoxic component/ALLERGAN) of 02.02.2016

European Case Law Identifier
ECLI:EP:BA:2016:T103611.20160202
Date of decision
2 February 2016
Case number
T 1036/11
Petition for review of
-
Application number
04019048.0
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Neurotoxic component of botulinum toxins for treating cervical dystonia
Applicant name
Allergan, Inc.
Merz Pharma GmbH & Co. KGaA
Opponent name
Solstice Neurosciences, Inc. (opposition withdrawn)
Board
3.3.04
Headnote
-
Relevant legal provisions
European Patent Convention Art 76(1)
Keywords
Divisional application - added subject-matter (yes)
Catchword
-
Citing cases
-

Order

For these reasons it is decided that:

The appeal is dismissed.